title: Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study.
authors.affiliation: University of Vermont College of Medicine, Burlington. Electronic address: Benjamin.Farahnik@med.uvm.edu.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Farahnik
authors.affiliation: University of California Los Angeles, David Geffen School of Medicine, Los Angeles.
authors.forename: Kourosh
authors.initials: K
authors.lastname: Beroukhim
authors.affiliation: University of California San Francisco, School of Medicine.
authors.forename: Melissa
authors.initials: M
authors.lastname: Danesh
authors.affiliation: University of California San Francisco, Department of Dermatology, Psoriasis and Skin Treatment Center.
authors.forename: Mio
authors.initials: M
authors.lastname: Nakamura
authors.affiliation: University of California Irvine, School of Medicine.
authors.forename: Michael
authors.initials: M
authors.lastname: Abrouk
authors.affiliation: University of Southern California Keck School of Medicine, Los Angeles.
authors.forename: Tian Hao
authors.initials: TH
authors.lastname: Zhu
authors.affiliation: University of California Los Angeles, David Geffen School of Medicine, Los Angeles.
authors.forename: Rasnik
authors.initials: R
authors.lastname: Singh
authors.affiliation: University of California San Francisco, Department of Dermatology, Psoriasis and Skin Treatment Center.
authors.forename: Kristina
authors.initials: K
authors.lastname: Lee
authors.affiliation: University of California San Francisco, Department of Dermatology, Psoriasis and Skin Treatment Center.
authors.forename: Tina
authors.initials: T
authors.lastname: Bhutani
authors.affiliation: University of California San Francisco, Department of Dermatology, Psoriasis and Skin Treatment Center.
authors.forename: John
authors.initials: J
authors.lastname: Koo
mesh_terms: D000279:Administration, Cutaneous; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000982:Antipruritics / Q000008:administration & dosage / Q000627:therapeutic use; D003033:Coal Tar / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010865:Pilot Projects; D011446:Prospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000379:methods*
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000982:Antipruritics; D007641:Keratolytic Agents; D003033:Coal Tar